News

BeiGene gets EU backing for neck and head cancer treatment
BeiGene (NASDAQ:ONC) (OTCPK:BEIGF) announced that an advisory committee of the European Medicines Agency (EMA), endorsed its ...
EU drugs regulator confirms suicidal thoughts as side effect of hair loss drug
The European drugs regulator said on Thursday its safety panel has confirmed suicidal thoughts as a side effect of anti-hair-loss drug finasteride and its generic versions, following an EU-wide review ...
Medscape11d
Blenrep Gets European Nod to Treat Multiple Myeloma
Adding Blenrep to standard therapy prolonged progression-free survival in patients with relapsed or refractory multiple ...
Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in short bowel syndrome
No. 10 / 2025 Zealand Pharma submits Marketing Authorization Application to the European Medicines Agency for glepaglutide in ...
Medscape11d
Generic Version of HIV Drug Recommended for EU
The two active substances are antivirals that inhibit HIV reverse transcriptase through incorporation into the viral DNA, ...
pharmaphorum8d
Autolus closes on EU okay for leukaemia cell therapy
Autolus' CAR-T cell therapy for a rare and aggressive form of acute lymphoblastic leukaemia (ALL), Aucatzyl, has been ...
Pharmabiz9d
EMA grants conditional marketing authorization to Autolus’ Aucatzyl to treat adults with acute lymphoblastic leukaemia
EMA grants conditional marketing authorization to Autolus’ Aucatzyl to treat adults with acute lymphoblastic leukaemia: Amsterdam, The Netherlands Monday, May 26, 2025, 16:00 Hr ...